Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform. G2B-002, Gate2Brain flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare paediatric cancers.
| Website | http://www.gate2brain.com |
| Employees | 11 (4 on RocketReach) |
| Founded | 2020 |
| Technologies |
HTML
,
PHP
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Drug Delivery Technology, Innovative Drug Delivery, Peptide Drug Development, Therapeutics Development, Pharmaceutical Technology, Central Nervous System Drugs, Neurological Therapeutics, Drug Delivery Platform, Innovative Biotechnology, Advanced Drug Delivery, Biotechnological Innovation, Pharmaceutical Innovation |
| Competitors | Novartis, Pfizer, Biogen, CureVac, Vapotherm, Lilly India, NantKwest, Otonomy, Inc, NeuroRx, Axovant Sciences Ltd +35 more (view full list) |
Looking for a particular Gate2Brain employee's phone or email?
Meritxell Teixido is the CEO and CSO of Gate2Brain.
4 people are employed at Gate2Brain.